TGFB1 and hepatocellular carcinoma: A third group comprises HCC-T and HCC-M, also representing late stage disease, but displaying counter regulation of TGF-β signaling via linker phosphorylation, which is reflected in a completely unusual setting in regard to our biochemical analyses.